PharmAI GmbH has become a 100% subsidiary of PharmAI Discovery GmbH. This integration strengthens PharmAI’s position in the AI-driven drug discovery field by unifying teams, intellectual property, and strategic focus under one structure. The consolidated organization continues to accelerate innovation and deliver advanced in silico discovery solutions to pharmaceutical and biotech partners worldwide.
